The great revolution against Alzheimer’s: ‘It’s the first time in human history that we’ve managed to slow the disease’

The fight against Alzheimer’s has entered a new era. The emergence of new drugs that slightly slow its progression, along with the discovery of biomarkers that pave the way for early detection, has renewed hope for tackling a condition that affects 50 million people worldwide. After decades of setbacks and the failure to find effective treatments for a dementia that destroys memory and individual autonomy, the scientific community is watching with anticipation the diagnostic and pharmacological revolution underway. A panel of experts published a series of articles in The Lancet on Monday detailing these advances, while also addressing the major controversy surrounding the new treatments — the first to alter the course of the disease, but criticized for being expensive, having side effects, and showing only modest efficacy.

Seguir leyendo